✦ LIBER ✦

Losartan intervention for endpoint reduction in hypertension (the life study)

✍ Scribed by DAHLOF, B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

H35 Baseline characteristics of the life

✍ B. Dahlöf; R. Devereux; U. DeFaire; F. Fyhrquist; T. Hedner; H. Ibsen; S. Julius 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 285 KB

Cardiovascular morbidity and mortality i

✍ Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beever 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 124 KB

Population impact of losartan use on str

✍ Dahlöf, B; Burke, T A; Krobot, K; Carides, G W; Edelman, J M; Devereux, R B; Die 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

The Effect of Losartan Versus Atenolol o

✍ Eigil Fossum; Andreas Moan; Sverre E. Kjeldsen; Richard B. Devereux; Stevo Juliu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Crumbling of left ventricular hypertroph

✍ Franz H Messerli; Mandeep R Mehra 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Body Build and Risk of Cardiovascular Ev

✍ G. de Simone; K. Wachtell; V. Palmieri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB